Back to top
more

NA (SSH)

(Delayed Data from NSDQ)

$0.61 USD

0.61
157,967

-0.02 (-2.47%)

Updated May 23, 2017 03:59 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

NA

Industry: NA

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Brokerage Reports

0 items in cart

Nuwellis, Inc. [SSH]

Reports for Purchase

Showing records 1 - 14 ( 14 total )

Company: Nuwellis, Inc.

Industry: Medical - Instruments

Record: 1

09/17/2014

Company Report

Pages: 3

Making progress on the Clinical Front and its Fully Implantable Device

Provider: The Benchmark Company

Analyst: WALD J

Price: 10.00

Research Provided by a Third Party

Company: Nuwellis, Inc.

Industry: Medical - Instruments

Record: 2

08/12/2014

Company Report

Pages: 3

Enrollment is the Story, And We Haven''t Hit Inflection Yet

Provider: The Benchmark Company

Analyst: WALD J

Price: 10.00

Research Provided by a Third Party

Company: Nuwellis, Inc.

Industry: Medical - Instruments

Record: 3

05/13/2014

Company Report

Pages: 3

Beginning to Make Solid Progress on its Clinical Trials

Provider: The Benchmark Company

Analyst: WALD J

Price: 10.00

Research Provided by a Third Party

Company: Nuwellis, Inc.

Industry: Medical - Instruments

Record: 4

04/14/2014

Company Report

Pages: 3

Let the Data Begin to Tell the Story--ISHLT Posters

Provider: The Benchmark Company

Analyst: WALD J

Price: 10.00

Research Provided by a Third Party

Company: Nuwellis, Inc.

Industry: Medical - Instruments

Record: 5

03/12/2014

Daily Note

Pages: 11

Morning Call

Provider: The Benchmark Company

Price: 25.00

Research Provided by a Third Party

Company: Nuwellis, Inc.

Industry: Medical - Instruments

Record: 6

03/11/2014

Company Report

Pages: 12

Trial Enrollment Slow, Long-term Prospects Remain Unchanged

Provider: The Benchmark Company

Analyst: WALD J

Price: 25.00

Research Provided by a Third Party

Company: Nuwellis, Inc.

Industry: Medical - Instruments

Record: 7

01/27/2014

Company Report

Pages: 13

Sunshine Heart: A Better Adverse Event Profile than VADs Could Ultimately Foster Utilization

Provider: The Benchmark Company

Analyst: WALD J

Price: 50.00

Research Provided by a Third Party

Company: Nuwellis, Inc.

Industry: Medical - Instruments

Record: 8

01/27/2014

Daily Note

Pages: 10

Morning Call

Provider: The Benchmark Company

Price: 25.00

Research Provided by a Third Party

Company: Nuwellis, Inc.

Industry: Medical - Instruments

Record: 9

01/13/2014

Company Report

Pages: 9

Sunshine Heart: Update In Line with our Expectations, More Color on Trials

Provider: The Benchmark Company

Analyst: WALD J

Price: 25.00

Research Provided by a Third Party

Company: Nuwellis, Inc.

Industry: Medical - Instruments

Record: 10

12/30/2013

Industry Report

Pages: 11

Equity Research Best Ideas for 2014

Provider: The Benchmark Company

Price: 25.00

Research Provided by a Third Party

Company: Nuwellis, Inc.

Industry: Medical - Instruments

Record: 11

11/11/2013

Company Report

Pages: 12

Progress as Expected on all Fronts; Things keep moving along

Provider: The Benchmark Company

Analyst: WALD J

Price: 25.00

Research Provided by a Third Party

Company: Nuwellis, Inc.

Industry: Medical - Instruments

Record: 12

11/01/2013

Industry Report

Pages: 6

TCT Meeting Update

Provider: The Benchmark Company

Analyst: WALD J

Price: 25.00

Research Provided by a Third Party

Company: Nuwellis, Inc.

Industry: Medical - Instruments

Record: 13

10/01/2013

Company Report

Pages: 23

Initiating with a Speculative Buy Rating and $16 Price Target

Provider: The Benchmark Company

Analyst: WALD J

Price: 75.00

Research Provided by a Third Party

Company: Nuwellis, Inc.

Industry: Medical - Instruments

Record: 14

10/01/2013

Daily Note

Pages: 8

Morning Call

Provider: The Benchmark Company

Price: 25.00

Research Provided by a Third Party
// eof